From: Taking part in a pharmacogenetic clinical trial: assessment of trial participants understanding of information disclosed during the informed consent process
Contacted
Interviewed
Response rate
London
Completers
25
16
64%
Drop outs
7
2
29%
Mannheim
42
38%
31
3
9.7%
Aarhus
40
19
47.5%
0
Poznan
100
15
15%
5
5%